Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.3700
+0.0008 (0.22%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Mustang Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.03 | -1.92 | -15.75 | -51.6 | -77.53 | -66.37 |
Depreciation & Amortization | - | 0.04 | 0.82 | 2.23 | 3.03 | 2.31 |
Other Amortization | - | - | - | 0.12 | 0.47 | - |
Loss (Gain) From Sale of Assets | - | - | 0.03 | -1.47 | 0.26 | - |
Asset Writedown & Restructuring Costs | - | - | 3.94 | 0.05 | 0.37 | 1.63 |
Stock-Based Compensation | 0.09 | 0.13 | -0.45 | 0.57 | 2.28 | 3.31 |
Other Operating Activities | -0.97 | -1.83 | -1.76 | 3.61 | 2.03 | 6.1 |
Change in Accounts Receivable | - | 0.44 | 0.49 | -3.58 | -0 | -0.04 |
Change in Accounts Payable | -0.71 | -1.97 | -0.59 | 0.13 | 5.26 | -0.41 |
Change in Unearned Revenue | - | - | -0.12 | - | - | 0.27 |
Change in Other Net Operating Assets | 0.1 | -0.15 | 1.97 | 0.48 | -1.23 | -0.46 |
Operating Cash Flow | -4.51 | -5.26 | -11.41 | -49.48 | -65.07 | -53.67 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | - | -0.06 | -2.71 | -3.99 |
Sale of Property, Plant & Equipment | - | 1.17 | - | 6 | 0.13 | - |
Sale (Purchase) of Intangibles | - | - | - | -0.05 | -0.37 | -1.38 |
Investing Cash Flow | - | 1.17 | - | 5.89 | -2.95 | -5.37 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | 30 | - |
Total Debt Issued | - | - | - | - | 30 | - |
Long-Term Debt Repaid | - | - | - | -30.38 | - | - |
Total Debt Repaid | - | - | - | -30.38 | - | - |
Net Debt Issued (Repaid) | - | - | - | -30.38 | 30 | - |
Issuance of Common Stock | 7.15 | 14.53 | 11.27 | 4.74 | 6.83 | 72.23 |
Other Financing Activities | -0.14 | - | - | -0.45 | -2.77 | -1.38 |
Financing Cash Flow | 7 | 14.53 | 11.27 | -26.08 | 34.06 | 70.85 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 2.49 | 10.43 | -0.15 | -69.67 | -33.96 | 11.81 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.51 | -5.26 | -11.41 | -49.54 | -67.78 | -57.65 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.69 | -1.07 | -18.71 | -287.98 | -441.02 | -492.00 |
Levered Free Cash Flow | -4.27 | -4.15 | -6.83 | -33.04 | -44.07 | -40.59 |
Unlevered Free Cash Flow | -4.27 | -4.15 | -6.83 | -30.59 | -42.44 | -40.58 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | 1.34 | 2.71 | - |
Change in Working Capital | -0.6 | -1.68 | 1.76 | -2.98 | 4.03 | -0.64 |